Table 3 Logistic regression models analyzing association of SCD and sociodemographic variables with stunting, wasting, and underweight
|  | Stunting (HAZ < − 2 SD) | Wasting (WHZ < − 2 SD) | Underweight (WAZ < − 2 SD) | |||
|---|---|---|---|---|---|---|
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
Sickle cell status: | ||||||
 Non-sickle cell (Hb AA) | 1 | 1 | 1 | 1 | 1 | 1 |
 Sickle cell and Hb C traits (Hb AS, AC) | 1.09 (0.97–1.20) | 1.07 (0.98–1.25) | 1.01 (0.86–1.42) | 1.09 (0.85–1.41) | 1.06 (0.94–1.21) | 1.07 (0.94–1.23) |
 Sickle cell disease (Hb SS, SC) | 2.02 (1.24–3.27) | 2.39 (1.26–4.54) | 1.43 (0.74–2.76) | 1.60 (0.85–3.02) | 2.28 (1.26–4.14) | 2.64 (1.25–5.98) |
Age (in months): | ||||||
 6–23 | 1 | 1 | 1 | 1 | 1 | 1 |
 24–40 | 1.66 (1.48–1.86) | 1.74 (1.53–1.98) | 0.34 (0.27–0.43) | 0.34 (0.27–0.43) | 1.02 (0.90–1.16) | 1.01 (0.88–1.16) |
 41–59 | 1.22 (1.10–1.37) | 1.26 (1.12–1.41) | 0.29 (0.23–0.36) | 0.28 (0.22–0.36) | 0.86 (0.76–0.97) | 0.86 (0.76–0.97) |
Sex: | ||||||
 Male | 1 |  | 1 | 1 | 1 | 1 |
 Female | 0.79 (0.72–0.86) | 0.76 (0.70–0.83) | 0.64 (0.54–0.79) | 0.65 (0.55–0.78) | 0.84 (0.76–83) | 0.83 (0.75–0.92) |
SES: | ||||||
 Richest | 1 | 1 | 1 | 1 | 1 | 1 |
 Middle-status | 2.32 (1.99–2.71) | 2.36 (1.31–1.84) | 1.68 (1.26–2.22) | 1.71 (1.29–2.26) | 2.14 (1.75–2.60) | 2.16 (1.79–2.61) |
 Poorest | 4.48 (3.85–5.22) | 4.60 (3.95–5.36) | 2.30 (1.77–2.97) | 2.38 (1.84–3.07) | 4.23 (3.50–5.12) | 4.28 (3.57–5.13) |